The DJBL improves glycemic status in obese subjects with diabetes and therefore represents a nonsurgical, reversible alternative to bariatric surgery.

Tumor bleeding is the most common cause of UGIB in cancer patients. UGIB in cancer patients correlates with a high mortality rate regardless of the bleeding source. Current endoscopic treatments may not be effective in preventing rebleeding or improving survival.

ESD and TEM are both safe and effective for the treatment of early rectal cancer.

The use of self-expandable metallic stents has increased recently to palliate inoperable esophageal neoplasia and also in the management of benign strictures. Migration is one of the most common complications after stent placement and the endoscopist should be able to recognize and manage this situation. Several techniques for managing migrated stents have been described, as well as new techniques for preventing stent migration. Most stents have a "lasso" at the upper flange which facilitates stent repositioning or removal. An overtube, endoloop and large polypectomy snare may be useful for the retrieval of stents migrated into the stomach. External fixation of the stent with Shim's technique is efficient in preventing stent migration. Suturing the stent to the esophageal wall, new stent designs with larger flanges and double-layered stents are promising techniques to prevent stent migration but they warrant validation in a larger cohort of patients.© 2014 Baishideng Publishing Group Co., Limited. All rights reserved.Key words: Endoscopy; Stents; Esophageal cancer; Benign strictures; Complications Core tip: Migration of self-expandable esophageal stents occurs in up to 36% of cases. The lasso system available in most stents provides a safe way to remove or reposition the stent while it is still in the esophagus. However, when the stent migrates into the stomach, other techniques are needed to guarantee a safer retrieval. The use of clipping, suturing or external fixation should be considered for stents at high risk for migration.Martins BC, Retes FA, Medrado BF, Lima MS, Pennacchi CMPS, Kawaguti FS, Safatle-Ribeiro AV, Uemura RS, MalufFilho F. Endoscopic management and prevention of migrated esophageal stents. World J Gastrointest Endosc 2014; 6(2): 49-54 Available from:

The duodenal-jejunal bypass liner improves glycaemia in overweight and obese patients with Type 2 diabetes by rapidly improving insulin sensitivity. A reduction in hepatic glucose output is the most likely explanation for this improvement.

The improvements in glycemic status were observed at 1 year in moderately obese subjects with T2DM, suggesting that the DJBL may represent an effective adjuvant to standard medical therapy of T2DM in this population.

No abstract

The DJBL, when used for a period of 6 months, is effective in the control of diabetes, weight loss, improvement of insulin resistance, and decrease of cardiovascular risk among morbidly obese patients with type 2 diabetes mellitus.